These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 345424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans.
    Fasoli MO, Kerridge D, Ryley JF.
    J Med Vet Mycol; 1990; 28(1):27-34. PubMed ID: 2194016
    [Abstract] [Full Text] [Related]

  • 3. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine.
    Auger P, Dumas C, Joly J.
    J Infect Dis; 1979 May; 139(5):590-4. PubMed ID: 374653
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
    Hamra LK, Pankiewicz IJ.
    Med J Aust; 1977 Nov 26; 2(22):749-50. PubMed ID: 347230
    [Abstract] [Full Text] [Related]

  • 6. Segregation of 5-fluorocytosine-resistance variants by Candida albicans.
    Whelan WL, Beneke ES, Rogers AL, Soll DR.
    Antimicrob Agents Chemother; 1981 Jun 26; 19(6):1078-81. PubMed ID: 7023383
    [Abstract] [Full Text] [Related]

  • 7. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL, Markie D, Kwon-Chung KJ.
    Antimicrob Agents Chemother; 1986 May 26; 29(5):726-9. PubMed ID: 3524427
    [Abstract] [Full Text] [Related]

  • 8. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.
    Defever KS, Whelan WL, Rogers AL, Beneke ES, Veselenak JM, Soll DR.
    Antimicrob Agents Chemother; 1982 Nov 26; 22(5):810-5. PubMed ID: 6758690
    [Abstract] [Full Text] [Related]

  • 9. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ, Edwards JE, Guze LB.
    J Infect Dis; 1975 Jul 26; 132(1):82-6. PubMed ID: 1097545
    [Abstract] [Full Text] [Related]

  • 10. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH, Liushih RN, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May 26; 15(2):106-12. PubMed ID: 7047097
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G, Sobral T, Ferreira AF.
    Mycopathologia; 1981 Jan 30; 73(1):39-41. PubMed ID: 7012631
    [Abstract] [Full Text] [Related]

  • 12. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Normark S, Schönebeck J.
    Antimicrob Agents Chemother; 1972 Sep 30; 2(3):114-21. PubMed ID: 4597703
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V, Torosantucci A, Simonetti N.
    Chemioterapia; 1984 Apr 30; 3(2):119-25. PubMed ID: 6398120
    [Abstract] [Full Text] [Related]

  • 14. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. I.--Relation between the phenotypes of resistance to 5-fluorocytosine, the serotype of Candida albicans and the ecology of various species of Candida of human origin (author's transl)].
    Drouhet E, Mercier-Soucy L, Montplaisir S.
    Ann Microbiol (Paris); 1975 Apr 30; 126B(1):25-39. PubMed ID: 1108732
    [Abstract] [Full Text] [Related]

  • 15. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A, Bergogne-Berezin E, Courtoux D.
    Ann Biol Clin (Paris); 1978 Apr 30; 36(2):69-74. PubMed ID: 358866
    [Abstract] [Full Text] [Related]

  • 16. [Sensitivity of yeasts against 5 fluorocytosine. Comparison of five methods (author's transl)].
    Brinkmann F.
    Z Hautkr; 1981 Oct 01; 56(19):1255-63. PubMed ID: 7032101
    [Abstract] [Full Text] [Related]

  • 17. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH, Sarosi GA.
    Chemotherapy; 1982 Oct 01; 28(5):341-4. PubMed ID: 6754278
    [Abstract] [Full Text] [Related]

  • 18. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL, Kerridge D.
    Antimicrob Agents Chemother; 1984 Oct 01; 26(4):570-4. PubMed ID: 6393861
    [Abstract] [Full Text] [Related]

  • 19. [Sensitivity and resistance of Candida to 5-fluorocytosine. Relationship to the cell wall ultrastructure].
    Montplaisir S, Drouhet E, Nabarra B.
    C R Acad Hebd Seances Acad Sci D; 1975 May 21; 280(19):2211-3. PubMed ID: 807407
    [Abstract] [Full Text] [Related]

  • 20. [C. albicans spontaneous mutations determining 5-fluorocytosine resistance].
    Pawlik B, Barylak J.
    Med Dosw Mikrobiol; 1977 May 21; 29(4):301-7. PubMed ID: 340821
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.